NYSE ARCA | ETF
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index.
The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies" products and services.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.36% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.27% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.23% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.18% |
| IRTC | iRhythm Technologies Inc | Healthcare | Medical Devices | 2.18% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.18% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.16% |
| AORT | Artivion Inc | Healthcare | Medical Devices | 2.11% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.11% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.10% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.09% |
| STAA | STAAR Surgical Company | Healthcare | Medical Instruments & Supplies | 2.05% |
| ERF | Eurofins Scientific SE | Healthcare | Diagnostics & Research | 2.03% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.91% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 1.88% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.85% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.83% |
| SHL | Siemens Healthineers AG | Healthcare | Medical Devices | 1.82% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 1.78% |
| PKI | PerkinElmer Inc | Healthcare | Diagnostics & Research | 1.77% |